Carbohydrate quality and human health: a series of systematic reviews and meta-analyses
Open accessAbstract
BACKGROUND Previous systematic reviews and meta-analyses explaining the relationship between carbohydrate quality and health have usually examined a single marker and a limited number of clinical outcomes. We aimed to more precisely quantify the predictive potential of several markers, to determine which markers are most useful, and to establish an evidence base for quantitative recommendations for intakes of dietary fibre. METHODS We did a series of systematic reviews and meta-analyses of prospective studies published from database inception to April 30, 2017, and randomised controlled trials published from database inception to Feb 28, 2018, which reported on indicators of carbohydrate quality and non-communicable disease incidence, mortality, and risk factors. Studies were identified by searches in PubMed, Ovid MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials, and by hand searching of previous publications. We excluded prospective studies and trials reporting on participants with a chronic disease, and weight loss trials or trials involving supplements. Searches, data extraction, and bias assessment were duplicated independently. Robustness of pooled estimates from random-effects models was considered with sensitivity analyses, meta-regression, dose-response testing, and subgroup analyses. The GRADE approach was used to assess quality of evidence. FINDINGS Just under 135 million person-years of data from 185 prospective studies and 58 clinical trials with 4635 adult participants were included in the analyses. Observational data suggest a 15-30% decrease in all-cause and cardiovascular related mortality, and incidence of coronary heart disease, stroke incidence and mortality, type 2 diabetes, and colorectal cancer when comparing the highest dietary fibre consumers with the lowest consumers Clinical trials show significantly lower bodyweight, systolic blood pressure, and total cholesterol when comparing higher with lower intakes of dietary fibre. Risk reduction associated with a range of critical outcomes was greatest when daily intake of dietary fibre was between 25 g and 29 g. Dose-response curves suggested that higher intakes of dietary fibre could confer even greater benefit to protect against cardiovascular diseases, type 2 diabetes, and colorectal and breast cancer. Similar findings for whole grain intake were observed. Smaller or no risk reductions were found with the observational data when comparing the effects of diets characterised by low rather than higher glycaemic index or load. The certainty of evidence for relationships between carbohydrate quality and critical outcomes was graded as moderate for dietary fibre, low to moderate for whole grains, and low to very low for dietary glycaemic index and glycaemic load. Data relating to other dietary exposures are scarce. INTERPRETATION Findings from prospective studies and clinical trials associated with relatively high intakes of dietary fibre and whole grains were complementary, and striking dose-response evidence indicates that the relationships to several non-communicable diseases could be causal. Implementation of recommendations to increase dietary fibre intake and to replace refined grains with whole grains is expected to benefit human health. A major strength of the study was the ability to examine key indicators of carbohydrate quality in relation to a range of non-communicable disease outcomes from cohort studies and randomised trials in a single study. Our findings are limited to risk reduction in the population at large rather than those with chronic disease. FUNDING Health Research Council of New Zealand, WHO, Riddet Centre of Research Excellence, Healthier Lives National Science Challenge, University of Otago, and the Otago Southland Diabetes Research Trust.
AI snapshot
Written from the paper’s full text.
TL;DR
This series of systematic reviews and meta-analyses found that higher intakes of dietary fibre and whole grains are associated with lower risk of non-communicable disease incidence and mortality, with dietary fibre intakes of 25–29 g/day showing greatest benefit. Glycaemic index/load were less useful markers, with low or very-low quality evidence and inconsistent trial effects.
Key findings
- Across 135 million person-years of prospective data and 58 trials with 4,635 adults, higher versus lowest total dietary fibre was associated with a 15–31% lower risk of critical outcomes; all-cause mortality RR 0.85 (95% CI 0.79–0.91), CHD incidence RR 0.76 (0.69–0.83), type 2 diabetes incidence RR 0.84 (0.78–0.90), and colorectal cancer incidence RR 0.84 (0.78–0.89).
- Greatest risk reduction for fibre occurred at 25–29 g/day (improvement in 6 of 7 critical outcomes); dose-response curves were often linear with no plateau, suggesting higher intakes may confer additional protection against cardiovascular diseases, type 2 diabetes, and colorectal and breast cancer.
- Higher whole grain intake was associated with a 13–33% lower risk; per 15 g/day higher intake, RRs were 0.94 (0.92–0.95) for all-cause mortality, 0.93 (0.89–0.98) for CHD incidence, 0.88 (0.81–0.95) for type 2 diabetes, and 0.97 (0.95–0.99) for colorectal cancer.
- Low glycaemic index diets showed an 11% (95% CI 3–18%) relative risk reduction in type 2 diabetes, attenuated to 5% (13% less to 4% more) in sensitivity analysis; evidence was graded low to very-low, and trials showed no consistent benefits.
Methods
- Systematic reviews and meta-analyses of prospective studies published before April 2017 and randomised controlled trials published before February 2018, identified via PubMed, Ovid Medline, Embase, Cochrane CENTRAL, and other sources, with duplicate independent searches, extraction, and bias assessment.
- Included 185 publications of prospective studies involving just under 135 million person-years and 58 clinical trials with 4,635 adult participants; outcomes included NCD incidence, mortality, and cardiometabolic risk factors.
- Random-effects models for high-versus-low quantile analyses, dose-response testing (linear and spline), sensitivity analyses, meta-regression, subgroup analyses, and GRADE assessment of evidence quality.
Limitations
- Stated: Evidence was most often graded moderate or low rather than high because GRADE typically requires RCTs with disease endpoints for high quality, and unexplained heterogeneity led to downgrading; data on other dietary exposures and specific fibre sources/subcategories were limited.
- Stated: High fibre and whole grain intakes may have deleterious effects in populations with borderline iron/mineral status, where very high whole grain intakes may further compromise iron status.
- Evident from text: Observational associations cannot prove causality, though authors argue consistency and dose-response make causality likely; glycaemic index/load findings were inconsistent and attenuated in sensitivity analyses; trials excluded weight-loss trials, fibre supplement powders, and people with diabetes or marked hyperlipidaemia, limiting generalisability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 31 cited sources checked · 0 supported · 0 flagged
- Findingnone given
The findings from prospective studies of glycaemic load are inconsistent.
“The findings from prospective studies of glycaemic load are inconsistent.”
Quote in the paperSubstantial claim - Findingown data
Higher whole grain intake is associated with a 13-33% reduction in risk of critical outcomes.
“Higher intakes of whole grains were associated with a 13-33% reduction in the risk.”
Quote in the paperSubstantial claim - Findingown data
Smaller or no risk reductions were found with observational data when comparing effects of diets characterised by low rather than higher glycaemic index or load.
“Smaller or no risk reductions were found with the observational data when comparing the effects of diets characterised by low rather than higher glycaemic index or load.”
Quote in the paperSubstantial claim - Findingnone given
Randomised controlled trials involving an increase in whole grains showed improvements in body weight and lipids.
“The randomised controlled trials involving an increase in the amount of whole grains showed improvements in body weight and lipids.”
Quote in the paperSubstantial claim - Findingown data
Risk reduction associated with a range of critical outcomes was greatest when daily intake of dietary fibre was between 25-29 grams.
“Risk reduction associated with a range of critical outcomes was greatest when daily intake of dietary fibre was between 25-29 grams.”
- Also stated in: § Dietary fibre · plain
“When comparing the lowest fibre intakes with pre-specified ranges the greatest benefits were observed for those consuming 25-29g per day (improvement in 6 of the 7 critical outcomes), more so than those consuming between 15-19g per day (improvement in 3 of the 7 critical outcomes), or 20-24g per day (improvement in 4 of the 7 critical outcomes).”
Quote in the paperSubstantial claim - Also stated in: § Dietary fibre · plain
- Findingown data
The results from trials show no consistent benefits on clinical outcomes when changing the glycaemic index of a diet.
“The results from trials show no consistent benefits on the clinical outcomes when changing the glycaemic index of a diet.”
Quote in the paperSubstantial claim - Findingown data
Higher total dietary fibre intake is associated with a 15-31% reduction in risk of specified critical outcomes (all-cause mortality, coronary heart disease incidence, stroke, type 2 diabetes, and colorectal cancer) compared with lower intake.
“Observational data suggest a 15-30% decrease in all-cause and cardiovascular related mortality, and incidence of coronary heart disease, stroke, type 2 diabetes, and colorectal cancer when comparing the highest dietary fibre consumers with the lowest.”
- Also stated in: § Dietary fibre · plain
“The observational data in Table 1 show that higher intakes of total dietary fibre are associated with a 15-31% reduction in the risk of specified critical outcomes.”
Quote in the paperSubstantial claim - Also stated in: § Dietary fibre · plain
- Findingown data
Total dietary fibre intake is associated with a reduced risk ratio of 0.92 (0.89 to 0.95) for colorectal cancer incidence per 8 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•92 (0•89 to 0•95) was observed for every 8 grams more fibre consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Sensitivity analysis due to high heterogeneity attenuated the relative risk reduction for type 2 diabetes from low glycaemic index diets to 5% (95%CI 13% less to 4% more).
“However sensitivity analysis due to high heterogeneity attenuated the relative risk reduction to 5% (95%CI 13% less to 4% more).”
Quote in the paperSubstantial claim - Findingown data
Total dietary fibre intake is associated with a reduced risk ratio of 0.93 (0.90 to 0.95) for all-cause mortality per 8 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•93 (0•90 to 0•95) was observed for every 8 grams more fibre consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Total dietary fibre intake is associated with a reduced risk ratio of 0.85 (0.82 to 0.89) for type 2 diabetes incidence per 8 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•85 (0•82 to 0•89) was observed for every 8 grams more fibre consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingnone given
Stroke mortality was lower amongst those consuming lower glycaemic index diets.
“Stroke mortality was lower amongst those consuming lower glycaemic index diets.”
Quote in the paperNot a substantial claim - Findingown data
Total dietary fibre intake is associated with a reduced risk ratio of 0.81 (0.73 to 0.90) for coronary heart disease incidence per 8 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•81 (0•73 to 0•90) was observed for every 8 grams more fibre consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
An 11% (95%CI 3% to 18%) relative risk reduction of type 2 diabetes was observed for those consuming low glycaemic index diets.
“An 11% (95%CI 3% to 18%) relative risk reduction of type 2 diabetes was observed for those consuming low glycaemic index diets.”
Quote in the paperSubstantial claim - Findingown data
We found a reduced risk of stroke only for low glycaemic index or glycaemic load diets.
“whilst we found a reduced risk of stroke only.”
Quote in the paperSubstantial claim - Findingown data
Glycaemic index is associated with a risk ratio of 1.05 (1.00 to 1.10) for colorectal cancer incidence per 10 GI unit increase per day, assuming linearity.
“Assuming linearity a risk ratio of 1•05 (1•00 to 1•10) was observed for every 10 glycaemic index unit increase per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Glycaemic index is associated with a risk ratio of 1.09 (0.94 to 1.27) for coronary heart disease incidence per 10 GI unit increase per day, assuming linearity.
“Assuming linearity a risk ratio of 1•09 (0•94 to 1•27)was observed for every 10 glycaemic index unit increase per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Glycaemic index is associated with a risk ratio of 1.10 (1.00 to 1.20) for type 2 diabetes incidence per 10 GI unit increase per day, assuming linearity.
“Assuming linearity a risk ratio of 1•10 (1•00 to 1•20) was observed for every 10 glycaemic index unit increase per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Higher compared with lower total dietary fibre intake is associated with a mean difference of 0.37 kg lower body weight (0.63 to 0.11 kg lower) in randomised trials (high GRADE).
“Change in body weight (kg) | 27 | randomised trials | 1,294 | 1201 | MD 0•37 lower (0•63 kg lower to 0•11 kg lower) | High”
Quote in the paperSubstantial claim - Findingown data
We were unable to confirm an effect of low glycaemic index or glycaemic load diets on haemoglobin A1c or blood cholesterol.
“We were unable to confirm an effect of low glycaemic index or glycaemic load diets on haemoglobin A1 c or blood cholesterol which have been reported in many short and medium term trials.”
Quote in the paperSubstantial claim - Findingown data
Higher compared with lower total dietary fibre intake is associated with a standardised mean difference of 0.35 lower HbA1c (0.73 lower to 0.03 higher) in randomised trials (low GRADE).
“Change in HbA1c (%) | 6 | randomised trials | 191 | 189 | SMD 0•35 lower (0•73 lower to 0•03 higher) | Low”
Quote in the paperSubstantial claim - Findingown data
Wholegrain intake is associated with a reduced risk ratio of 0.97 (0.95 to 0.99) for colorectal cancer incidence per 15 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•97 (0•95 to 0•99) was observed for every 15 grams more whole grains consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.87 (0.79 to 0.95) for cancer mortality (moderate GRADE).
“Cancer mortality | 5 | observational | 29,593 | 11•2 million PY | RR 0•87 (0•79 to 0•95) | Moderate”
Quote in the paperSubstantial claim - Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.76 (0.69 to 0.83) for CHD incidence (moderate GRADE).
“CHD incidence | 9 | observational | 7,155 | 2•7 million PY | RR 0•76 (0•69 to 0•83) | Moderate”
Quote in the paperSubstantial claim - Findingown data
Wholegrain intake is associated with a reduced risk ratio of 0.93 (0.89 to 0.98) for coronary heart disease incidence per 15 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•93 (0•89 to 0•98) was observed for every 15 grams more whole grains consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.69 (0.60 to 0.81) for CHD mortality (moderate GRADE).
“CHD mortality | 10 | observational | 7,243 | 6•9 million PY | RR 0•69 (0•60 to 0•81)* | Moderate”
Quote in the paperSubstantial claim - Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.85 (0.79 to 0.91) for all-cause mortality (moderate GRADE).
“All-cause mortality | 10 | observational | 80,139 | 12•3 million PY | RR 0•85 (0•79 to 0•91) | Moderate”
Quote in the paperSubstantial claim - Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.80 (0.56 to 1.14) for stroke mortality (very low GRADE).
“Stroke mortality | 2 | observational | 1,103 | 1•3 million PY | RR 0•80 (0•56 to 1•14) | Very low”
Quote in the paperNot a substantial claim - Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.84 (0.78 to 0.90) for type 2 diabetes incidence (moderate GRADE).
“Type 2 diabetes incidence | 17 | observational | 48,468 | 6•9 million PY | RR 0•84 (0•78 to 0•90) | Moderate”
Quote in the paperSubstantial claim - Findingown data
Higher compared with lower total dietary fibre intake is associated with a mean difference of 0.15 mmol/L lower total cholesterol (0.22 to 0.07 lower) in randomised trials (moderate GRADE).
“Change in total cholesterol (mmol/L) | 36 | randomised trials | 1,832 | 1,671 | MD 0•15 lower** (0•22 lower to 0•07 lower) | Moderate”
Quote in the paperSubstantial claim - Findingown data
Glycaemic index is associated with a risk ratio of 1.16 (0.90 to 1.49) for all-cause mortality per 10 GI unit increase per day, assuming linearity.
“Assuming linearity a risk ratio of 1•16 (0•90 to 1•49) was observed for every 10 glycaemic index unit increase per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.84 (0.78 to 0.89) for colorectal cancer incidence (moderate GRADE).
“Colorectal cancer incidence | 22 | observational | 22,920 | 16•9 million PY | RR 0•84 (0•78 to 0•89) | Moderate”
Quote in the paperSubstantial claim - Findingown data
Wholegrain intake is associated with a reduced risk ratio of 0.94 (0.92 to 0.95) for all-cause mortality per 15 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•94 (0•92 to 0•95) was observed for every 15 grams more whole grains consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingown data
Higher compared with lower total dietary fibre intake is associated with a mean difference of 1.27 mm Hg lower systolic blood pressure (2.50 to 0.04 lower) in randomised trials (moderate GRADE).
“Change in systolic blood pressure (mm Hg) | 15 | randomised trials | 1,064 | 988 | MD 1•27 lower** (2•50 lower to 0•04 lower) | Moderate”
Quote in the paperSubstantial claim - Findingown data
Higher compared with lower total dietary fibre intake is associated with a relative risk of 0.78 (0.69 to 0.88) for stroke incidence (low GRADE).
“Stroke incidence | 9 | observational | 13,134 | 4•6 million PY | RR 0•78 (0•69 to 0•88)** | Low”
Quote in the paperSubstantial claim - Findingown data
Wholegrain intake is associated with a reduced risk ratio of 0.88 (0.81 to 0.95) for type 2 diabetes incidence per 15 g/day increase, assuming linearity.
“Assuming linearity a reduced risk ratio of 0•88 (0•81 to 0•95) was observed for every 15 grams more whole grains consumed per day.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
- Findingnone given
The types of studies we have considered did not identify risks associated with dietary fibre.
“The types of studies we have considered did not identify risks associated with dietary fibre.”
Quote in the paperSubstantial claim - Study design and conductown data
Evidence relating to body weight, cholesterol, and blood pressure for whole grains is graded as moderate, downgraded due to unexplained heterogeneity.
“Evidence relating to body weight, cholesterol, and blood pressure is graded as moderate, downgraded due to unexplained heterogeneity.”
Quote in the paperSubstantial claim - Study design and conductown data
The prospective studies on glycaemic index generated evidence graded as low or very-low quality as a result of high risk of bias, imprecision, and inconsistencies.
“The prospective studies generated evidence that is graded as low or very-low quality as a result of high risk of bias, imprecision, and inconsistencies.”
Quote in the paperSubstantial claim - Interpretationreasoning
Less useful markers of carbohydrate quality are glycaemic index, glycaemic load, and sources of dietary fibre where inconsistent findings or insufficient data provide low or very low quality evidence.
“Less useful markers of carbohydrate quality are glycaemic index, glycaemic load, and sources of dietary fibre where inconsistent findings or insufficient data provide low or very low quality evidence.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The evidence for associations between quality markers and outcomes was most frequently rated as 'moderate' or 'low' rather than 'high'.
“That the evidence for the associations between the quality markers and outcomes was most frequently rated as 'moderate' or 'low' rather than 'high' may be regarded as a limitation.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The complementary findings from prospective studies and clinical trials relating to reduction in mortality, NCD incidence, and risk factors associated with relatively high intakes of dietary fibre and whole grains, as well as dose response evidence, indicate that the relationships may be causal.
“The complementary findings from prospective studies and clinical trials relating to the reduction in mortality, NCD incidence, and their risk factors associated with relatively high intakes of dietary fibre and whole grains as well as striking dose response evidence indicate that the relationships may be causal.”
- Also stated in: § Discussion · hedged
“The consistency between the trial and prospective study results together with the dose response relationships are evidence that the effect on cardiometabolic diseases are likely to be causal and not a consequence of confounding.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response analysis assumes a linear relationship between intake and outcome.
- Also stated in: § Discussion · hedged
- Study design and conductnone given
The quality of evidence contributing to meta-analyses of cohort studies for total dietary fibre was considered moderate, except for stroke.
“The quality of evidence contributing to the meta analyses of the cohort studies was, with the exception of the data relating to stroke, considered to be moderate.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The similar protective effects of higher intakes of wholegrain foods and dietary fibre suggest that the beneficial effects of whole grains may be due to their typically high dietary fibre content.
“The similar protective effects of higher intakes of wholegrain foods and of dietary fibre suggest that the beneficial effects of whole grains may be due to their typically high dietary fibre content.”
Quote in the paperSubstantial claim - Study design and conductown data
Sensitivity analyses did not typically change the direction or significance of any pooled effect for whole grains.
“Sensitivity analyses did not typically change the direction or significance of any pooled effect.”
Quote in the paperNot a substantial claim - Study design and conductnone given
Trial data on decreasing glycaemic index were usually of moderate quality.
“Trial data were usually of moderate quality.”
Quote in the paperNot a substantial claim - Study design and conductown data
Sensitivity analyses of the tested associations did not change the direction or significance of any observed result for total dietary fibre.
“Sensitivity analyses of the tested associations did not change the direction or significance of any observed result.”
Quote in the paperNot a substantial claim - Interpretationcitation
The findings of this study are broadly comparable with other reviews and meta-analyses on the association between dietary fibre and whole grains and one or more disease outcomes.
“Our findings are broadly comparable with other reviews and meta analyses that have reported on the association between dietary fibre and whole grains and one or more disease outcomes.[25][26][27][28]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [25] Liu, 2015, Fiber consumption and all-cause, cardiovascular, and cancer mortalities: a systematic review and meta-analysis of cohort studies, Mol Nutr Food Res source
Not checked in the free run.
- cites [26] Barclay, 2008, Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies, Am J Clin Nutr source
Not checked in the free run.
- cites [27] Dong, 2011, Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies, Br J Nutr source
Not checked in the free run.
- Premisecitation
There is limited, but quite striking evidence that increased processing of whole grains can result in a deterioration of several biomarkers of cardiometabolic disease.
“There is limited, but quite striking evidence that increased processing of whole grains can result in a deterioration of a several biomarkers of cardiometabolic disease.48”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48]
Not checked in the free run.
- Premisecitation
Epidemiological evidence and relatively long term clinical trials suggest that a wide range of total carbohydrate intakes is acceptable.
“While we have not considered the evidence regarding total carbohydrate intake, epidemiological evidence and relatively long term clinical trials 46 suggest that a wide range of intakes is acceptable, a finding which is endorsed by authoritative dietary guidelines.47”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
The coming together of the epidemiological and experimental work on fibre allows conclusions to be drawn that increased fibre intakes should result in improvements in population health.
“This coming together of the epidemiological and experimental work on fibre allows conclusions to be drawn that increased fibre intakes should result in improvements in population health.”
Quote in the paperSubstantial claim - Interpretationown data
Our study contributes to the growing body of evidence that carbohydrate quality rather than quantity determines major health outcomes.
“Our study contributes to the growing body of evidence that carbohydrate quality rather than quantity determines major health outcomes.”
Quote in the paperSubstantial claim - Interpretationown data
There is less consistency in this study's findings than in earlier reports with regard to the potential benefit of low glycaemic index or glycaemic load diets.
“However there is less consistency in our findings than in earlier reports with regard to the potential benefit of low glycaemic index or glycaemic load diets.”
Quote in the paperSubstantial claim - Interpretationreasoning
Diets characterised by a low content of dietary fibre contribute to the cause of a number of NCDs.
“Our complementary findings from randomised controlled trials and prospective studies together with the dose response effects, supported by much experimental work, are evidence that diets characterised by a low content of dietary fibre contribute to the cause of a number of NCDs and that benefit will accrue from implementation of quantitative recommendations regarding dietary fibre intake.”
Quote in the paperSubstantial claim - Interpretationreasoning
High intakes of dietary fibre and whole grains are more clearly associated with good health outcomes than measures of glycaemic index or glycaemic load.
“High intakes of dietary fibre and whole grains are more clearly associated with good health outcomes than measures of glycaemic index or glycaemic load.”
Quote in the paperSubstantial claim
- May combine two claims. 31
- The quote only partly states this claim. 3
- Classified as probably not a substantial claim. 25
May combine two claims. The quote only partly states this claim.
Findingown dataDose response curves for total dietary fibre intake and total mortality, CHD incidence, type 2 diabetes and colorectal cancer are linear with no sign of a plateau within available data.
“Figure 2 shows dose response relationships for total fibre intake and total mortality, incidence of coronary heart disease, type 2 diabetes and colorectal cancer, many of which are linear with no sign of a plateau within the available data.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe risk estimates for glycaemic index, other than for stroke mortality, are modest compared with those for dietary fibre and following sensitivity analyses were reduced and associated with confidence intervals which included 1.
“However the risk estimates, other than for stroke mortality, are modest when compared with those for dietary fibre and following sensitivity analyses were reduced and associated with confidence intervals which included 1.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningThe observed reductions in risk for whole grains are considerable, typically around 20% with significant dose response relationships.
“As with dietary fibre the observed reductions in risk are considerable, typically around 20% with significant dose response relationships.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response analysis assumes a linear relationship between intake and outcome.
May combine two claims.
FindingreasoningProspective studies show reductions in all-cause mortality, coronary heart disease, cancer deaths, and incidence of type 2 diabetes with higher whole grain intake.
“Prospective studies showed a reduction in allcause mortality, coronary heart disease, cancer deaths, and incidence of type 2 diabetes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataClinical trials show significantly lower body weight, systolic blood pressure and total cholesterol when comparing higher with lower dietary fibre intakes.
“Clinical trials show significantly lower body weight, systolic blood pressure and total cholesterol when comparing higher with lower intakes.”
- Also stated in: § Discussion · plain
“In randomised trials higher intakes of dietary fibre reduce body weight, lower blood cholesterol and systolic blood pressure.”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
May combine two claims.
FindingreasoningFor all-cause mortality and coronary heart disease incidence, higher whole grain intake translates into 26 fewer deaths (95%CI 14 to 39) and 7 fewer cases (95%CI 3 to 10) per 1000 participants over the duration of the studies.
“For all-cause mortality and coronary heart disease incidence this translates into 26 fewer deaths (95%CI 14 to 39) and 7 fewer cases (95%CI 3 to 10) per 1000 participants over the duration of the studies.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDiets with a lower overall glycaemic index appear to be associated with a reduced risk of stroke and type 2 diabetes.
“We have found that diets with a lower overall glycaemic index appear to be associated with a reduced risk of stroke and type 2 diabetes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDose response curves show clear associations with increasing whole grain intake and all-cause mortality or risk of coronary heart disease, type 2 diabetes, and colorectal cancer incidence.
“Dose response curves showing clear associations with increasing wholegrain intake and all-cause mortality or risk of coronary heart disease, type 2 diabetes, and colorectal cancer incidence are shown in Figure 3.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response analysis assumes a linear relationship between intake and outcome.
May combine two claims.
FindingreasoningFor all-cause mortality and coronary heart disease incidence, higher total dietary fibre intake translates into 13 fewer deaths (95%CI 8 to 18) and 6 fewer cases of CHD (95%CI 4 to 7) per 1000 participants over the duration of the studies.
“For all-cause mortality and coronary heart disease incidence this translates into 13 fewer deaths (95%CI 8 to 18) and 6 fewer cases of CHD (95%CI 4 to 7) per 1000 participants over the duration of the studies.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the present study, sensitivity analyses due to high heterogeneity reduced risk reduction and confidence intervals included 1.
“In the present study sensitivity analyses due to high heterogeneity reduced risk reduction and confidence intervals included 1.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe quality of evidence contributing to meta-analyses of trial data relating to body weight is high and total cholesterol and systolic blood pressure moderate because of unexplained heterogeneity between trials.
“The quality of evidence contributing to the meta analyses of the trial data relating to body weight is high and total cholesterol and systolic blood pressure moderate because of unexplained heterogeneity between the trials.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenSearches, data extraction, and bias assessment were duplicated independently.
“Searches, data extraction, and bias assessment were duplicated independently.”
- Also stated in: § Methods · plain
“Literature searches, identification of eligible studies, data extraction and bias assessment were undertaken independently by at least two researchers, with discrepancies resolved with an additional reviewer.”
Quote in the paperSubstantial claim- Also stated in: § Methods · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFor prospective studies, analyses excluding those that scored less than six out of nine on NOS were conducted.
“For prospective studies analyses excluding those that scored less than six out of a possible nine with the NOS were conducted.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe approach enabled the authors to provide a stronger justification than previously available for a quantitative recommendation relating to dietary fibre intake.
“Our approach has enabled us to use these indicators of carbohydrate quality to provide a stronger justification than had previously been available for a quantitative recommendation relating to dietary fibre intake.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFunders except WHO had no role in study design, data collection, data analysis, data interpretation, or writing.
“With the exception of WHO, the funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing the report.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationPublication bias was assessed with Egger's and Begg's tests, and the trim and fill method.
“Publication bias was assessed with Egger's and Begg's tests, 18 and the trim and fill method.19”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [18] Duval, 2000, Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis, Biometrics source
Not checked in the free run.
- cites [19] Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ source
Not checked in the free run.
May combine two claims.
InterpretationreasoningHigher intakes of total dietary fibre or whole grains result in reduced incidence and mortality from several NCDs.
“Higher intakes of total dietary fibre or whole grains result in reduced incidence and mortality from several NCDs.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe quality of evidence relating to colorectal cancer incidence for whole grains is moderate, whilst for other critical outcomes it is low due to high heterogeneity not fully explained by sensitivity analysis.
“The quality of evidence relating to colorectal cancer incidence is moderate, whilst for other critical outcomes it is low due to high heterogeneity not fully explained by sensitivity analysis.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataHigher dietary fibre intakes may confer even greater benefit for cardiovascular diseases, type 2 diabetes, and colorectal and breast cancer.
“Dose response curves suggested that higher intakes may confer even greater benefit with regard to protection against cardiovascular diseases, type 2 diabetes and colorectal and breast cancer.”
- Also stated in: § Discussion · hedged
“These findings together with the comparisons of clinical outcomes amongst those with different intakes of dietary fibre suggest that individual adult intakes of total dietary fibre should be no less than 25 to 29 grams per day with additional benefits likely to accrue with higher intakes.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The dose-response analysis assumes a linear relationship between intake and outcome.
- Also stated in: § Discussion · hedged
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningFor clinical trials, analyses excluding trials with high risk of bias for at least one criterion were conducted.
“For clinical trials, analyses excluding trials with a high risk of bias for at least one criterion were conducted to examine the influence of potential bias on outcomes.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Premisenone givenThe use of GRADE criteria typically requires evidence from randomised controlled trials with disease endpoints to be rated as 'high'.
“However this is an inevitable consequence of the use of GRADE criteria for assessment which typically require evidence from randomised controlled trials with disease endpoints in order to be rated as being of 'high'.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMeta regression analyses examined effects of potential explanatory factors including trial design, duration, global region, differences in fibre intake achieved, source of fibre or starch and nutrition status.
“Meta regression analyses further examined effects of potential explanatory factors including trial design (crossover or parallel), study or trial duration, global region, differences in fibre intake achieved, source of fibre or starch and nutrition status of participants.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenWhen using GRADE, downgrading frequently occurs as a consequence of unexplained heterogeneity amongst results of different studies, even when all trend in similar direction.
“Furthermore when using the GRADE approach downgrading frequently occurs as a consequence of unexplained heterogeneity amongst the results of the different studies, even when all trend in a similar direction.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataOverall certainty of evidence regarding relationships between carbohydrate quality and critical outcomes was graded as moderate for dietary fibre, low to moderate for whole grains, and low to very-low for glycaemic index.
“Overall the certainty of evidence regarding the relationships between carbohydrate quality and critical outcomes was graded as moderate for dietary fibre, low to moderate for whole grains, and low to very-low for glycaemic index.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationGRADE protocols were used to judge quality of body of evidence as high, moderate, low, or very-low.
“We used GRADE 22 protocols, to judge the quality of the body of evidence as either high, moderate, low, or very-low.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Aune, 2016, Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies, BMJ source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenFor prospective studies, the most adjusted values for effect size were extracted, where that value did not also specifically include adjustment for other carbohydrates.
“For prospective studies the most adjusted values for effect size were extracted, where that value did not also specifically include adjustment for other carbohydrates.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWhere there were multiple publications from the same cohort, data for the longest follow-up period were used.
“Where there were multiple publications from the same cohort, we used data for the longest follow-up period.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductcitationRisk of bias was assessed using ROBIS for systematic reviews and meta-analyses, NOS for prospective studies, and Cochrane criteria for clinical trials.
“We used the ROBIS assessment tool 8 to assess systematic reviews and meta analyses for quality and risk of bias, and the Newcastle Ottawa Scale (NOS) 9 to assess risk of bias of each prospective study.For clinical trials we used Cochrane criteria.10”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [8] Whiting, 2016, ROBIS: a new tool to assess risk of bias in systematic reviews was developed, J Clin Epidemiol source
Not checked in the free run.
- cites [9] Wells, 2011
Not checked in the free run.
- cites [10] Higgins, 2011, The Cochrane collaboration's tool for assessing risk of bias in randomised trials, BMJ source
Not checked in the free run.
May combine two claims.
Study design and conductown dataThe study related key markers of carbohydrate quality to total mortality and mortality and incidence of major nutrition-related NCDs and considered prospective studies alongside randomised controlled trials.
“A major strength of the present study is that it has related key markers of carbohydrate quality to total mortality and mortality and incidence of the major nutrition-related non-communicable diseases and that prospective studies have been considered alongside randomised controlled trials.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenQuality of evidence was assessed by research team and revised if required after discussion with NUGAG Subgroup.
“Quality of the evidence was assessed by the research team and revised if required after discussion with the NUGAG Subgroup on Diet and Health.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationData were extracted using pre-tested forms.
“Data were extracted using pre-tested forms.7”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Te Morenga, 2013, Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies, BMJ source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe study followed reporting standards for systematic reviews and meta-analyses.
“We followed reporting standards for systematic reviews and meta analyses.6”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe corresponding author had full access to all data and final responsibility for decision to submit.
“The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Study design and conductown dataThe high heterogeneity of the pooled effect size (>50%) for stroke incidence and total cholesterol is unexplained by sensitivity analyses.
“** The high heterogeneity of the pooled effect size (>50%) is unexplained by sensitivity analyses.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationDiets high in total dietary fibre, especially from whole grains and vegetables and fruits, are associated with a significant reduction in a range of NCDs when compared with lower dietary fibre and refined rather than whole grain intakes.
“Diets high in total dietary fibre especially from whole grains and, on the basis of another recent systematic review, 36 vegetables and fruits, are associated with a significant reduction in a range of NCDs when compared with lower dietary fibre and refined rather than whole grain intakes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Cummings, 1973, Dietary fibre, Gut source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningOur study does not exclude the value of these indicators of carbohydrate quality in this clinical context.
“Our study does not exclude the value of these indicators of carbohydrate quality in this clinical context.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningWhole foods that require chewing and retain much of their structure in the gut are more likely to increase satiety through a variety of mechanisms leading to weight loss and to modulation of carbohydrate and lipid metabolism.
“Whole foods that require chewing and retain much of their structure in the gut are more likely to increase satiety through a variety of mechanisms leading to weight loss and to modulation of carbohydrate and lipid metabolism.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThere is a considerable body of evidence relating to the adverse consequences of high intakes of sugar sweetened beverages and strong recommendations to reduce the intake of free sugars.
“There is a considerable body of evidence relating to the adverse consequences of high intakes of sugar sweetened beverages and strong recommendations to reduce the intake of free sugars.3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] 2015
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningBenefit will accrue from implementation of quantitative recommendations regarding dietary fibre intake.
“Our complementary findings from randomised controlled trials and prospective studies together with the dose response effects, supported by much experimental work, are evidence that diets characterised by a low content of dietary fibre contribute to the cause of a number of NCDs and that benefit will accrue from implementation of quantitative recommendations regarding dietary fibre intake.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenWe excluded trials which involved only people with diabetes or marked hyperlipidaemia, who were the participants in the majority of trials reporting reduction in these important risk indicators.
“However we excluded trials which involved only people with diabetes or marked hyperlipidaemia who were the participants in the majority of trials reporting reduction in these important risk indicators.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther studies have reported a lower incidence of stroke and CHD amongst those consuming low glycaemic index or glycaemic load diets.
“Other studies have reported a lower incidence of stroke and CHD amongst those consuming low glycaemic index or glycaemic load diets, 29,[33][34][35][36]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [29] Turati, 2015, High glycemic index and glycemic load are associated with moderately increased cancer risk, Mol Nutr Food Res source
Not checked in the free run.
- cites [33] Rossi, 2015, Relation of dietary glycemic load with ischemic and hemorrhagic stroke: a cohort study in Greece and a meta-analysis, Eur J Nutr source
Not checked in the free run.
- cites [34] Aune, 2017, Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies, Int J Epidemiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAune et al. report risk reductions of around 10% per 200g fruit and vegetables combined for CHD, stroke and total mortality and smaller but still significant reductions for total cardiovascular disease and cancer.
“They report risk reductions of around 10% per 200g fruit and vegetables combined for CHD, stroke and total mortality and smaller but still significant reductions for total cardiovascular disease and cancer.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] Spiller, 2001
Not checked in the free run.
May combine two claims.
PremisecitationFoods containing added fructose or sucrose and composite foods containing both saturated fat and carbohydrate (e.g. confectionary products) may have a low glycaemic index.
“Foods containing added fructose or sucrose and composite foods containing both saturated fat and carbohydrate (e.g.confectionary products) may have a low glycaemic index.50”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe benefits of fibre reported in the present and other papers are supported by over 100 years of research into its chemistry, physical properties, physiology and metabolic effects.
“The benefits of fibre reported in the present and other papers are supported by over 100 years of research into its chemistry, physical properties, physiology and metabolic effects.23,[38][39][40]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [23] Aune, 2011, Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies, BMJ source
Not checked in the free run.
- cites [38] Clark, 2013, The effect of fiber on satiety and food intake: a systematic review, J Am Coll Nutr source
Not checked in the free run.
- cites [39] Wanders, 2011, Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials, Obes Rev source
Not checked in the free run.
May combine two claims.
Interpretationown dataWhole grains offer a useful means of increasing dietary fibre intake and reducing risk of NCDs.
“Whole grains offer a useful means of increasing dietary fibre intake and reducing risk of NCDs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA review of prospective studies by Turati et al. suggested a small but significant increase in colorectal cancer incidence associated with high glycaemic index or glycaemic load.
“A review of prospective studies by Turati et al. 32 suggested a small but significant increase in colorectal cancer incidence associated with high glycaemic index or glycaemic load.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Mirrahimi, 2012, Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts, J Am Heart Assoc source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
Study design and conductown dataEgger's test for bias for CHD mortality was p=0.0040; trim and fill analysis did not change the direction or significance of the pooled estimate.
“* Egger's test for bias p = 0•0040. Trim and fill analysis did not change the direction or significance of the pooled estimate.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationown dataOur findings based on a series of systematic reviews and meta-analyses provide strong evidence for the importance of including advice regarding the nature and source of other carbohydrates in dietary guidelines aimed at reducing the risk of NCDs.
“Our findings based on a series of systematic reviews and meta analyses provide strong evidence for the importance of including advice regarding the nature and source of other carbohydrates in dietary guidelines aimed at reducing the risk of NCDs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe principal function of the microbiome is digestion of fibre and other carbohydrates that escape breakdown in the small bowel and it is the availability of fibre in the diet that dominates the metabolism of the gut microbiome and leads to protection from conditions such as colorectal cancer.
“However the principal function of the microbiome is digestion of fibre and other carbohydrates that escape breakdown in the small bowel and it is the availability of fibre in the diet that dominates the metabolism of the gut microbiome and leads to protection from conditions such as colorectal cancer.44,45”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [44]
Not checked in the free run.
- cites [45] Järvi, 1999, Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients, Diabetes Care source
Not checked in the free run.
May combine two claims.
InterpretationreasoningIntakes in the range of 25 to 29 g daily are optimal, whilst the dose response data show that amounts greater than 30 g per day confer additional benefits.
“Intakes in the range of 25 to 29g daily are optimal whilst the dose response data show that amounts greater than 30g per day confer additional benefits.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThree systematic reviews have shown a reduced incidence of type 2 diabetes associated with the consumption of diets of lower glycaemic index or glycaemic load, though the effect was modest when compared with the protective effect of total dietary fibre or wholegrains.
“Three systematic reviews have shown a reduced incidence of type 2 diabetes associated with the consumption of diets of lower glycaemic index or glycaemic load, [29][30][31] though the effect was modest when compared with the protective effect of total dietary fibre or wholegrains.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [29] Turati, 2015, High glycemic index and glycemic load are associated with moderately increased cancer risk, Mol Nutr Food Res source
Not checked in the free run.
- cites [30] Cai, 2015, Carbohydrate intake, glycemic index, glycemic load, and stroke: a meta-analysis of prospective cohort studies, Asia Pac J Public Health source
Not checked in the free run.
- cites [31] Fan, 2012, Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis, PLoS One source
Not checked in the free run.
May combine two claims.
PremisecitationHigh intakes of dietary fibre and whole grains may be associated with deleterious effects in populations with borderline iron/mineral status, amongst whom very high whole grain intakes may further compromise iron status.
“However high intakes may be associated with deleterious effects in populations with borderline iron/mineral status, amongst whom very high whole grain intakes may further compromise iron status.49”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49]
Not checked in the free run.
The authors state this as an assumption.
The dose-response analysis assumes a linear relationship between intake and outcome.
“assuming linearity with a two-stage dose response random-effects analysis.”
The authors state this as an assumption.
The dose-response relationship between dietary fibre or wholegrain intake and the clinical outcomes is linear.
“Assuming linearity a reduced risk ratio of 0•93 (0•90 to 0•95) was observed for every 8 grams more fibre consumed per day.”
“Assuming linearity a reduced risk ratio of 0•94 (0•92 to 0•95) was observed for every 15 grams more whole grains consumed per day.”
“Assuming linearity a risk ratio of 1•16 (0•90 to 1•49) was observed for every 10 glycaemic index unit increase per day.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Prospective cohort studies have found dietary fiber intake is inversely associated with risk of type 2 diabetes.
“Regular intake of sufficient dietary fiber is associated with lower all-cause mortality in people with diabetes (173,174), and prospective cohort studies have found dietary fiber intake is inversely associated with risk of type 2 diabetes (175-177).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:<i>Standards of Care in Diabetes—2023</i> (2023) · cites this paper as [176]
Dietary fiber is an important dietary component for the prevention of chronic diseases and for ensuring gut microbiome diversity and metabolic functionality.
“Dietary fiber is an important dietary component for the prevention of chronic diseases 1 , 2 and to ensure gut microbiome diversity and metabolic functionality. 3”
From Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of <i>Bifidobacterium longum</i> (2024) · cites this paper as [1]
Higher doses of dietary fiber may be necessary for consistent health benefits.
“Thus, suggestions have been made that higher doses of dietary fiber may be necessary for consistent health benefits, 3 , 11 a notion supported by systematic reviews and meta-analyses. 1 , 12 , 13”
From Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of <i>Bifidobacterium longum</i> (2024) · cites this paper as [1]
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · see citing works
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859 · see citing works
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
(2014) · Medical Entomology and Zoology · Cited by 17,633 · see citing works
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · see citing works
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380 · see citing works
(1992) · PubMed · Cited by 3,809 · see citing works
Self-citationAune, D., Giovannucci, E., Boffetta, P., Fadnes, L. T., Keum, N., Norat, T., Greenwood, D. C., Riboli, E., Vatten, L. J., & Tonstad, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw319 · Cited by 2,419 · see citing works
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353 · see citing works
ROBIS: A new tool to assess risk of bias in systematic reviews was developed
Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272 · see citing works
International Tables of Glycemic Index and Glycemic Load Values: 2008
Atkinson, F. S., Foster-Powell, K., & Brand-Miller, J. C. (2008) · Diabetes Care · doi:10.2337/dc08-1239 · Cited by 1,965 · see citing works
Te Morenga, L., Mallard, S., & Mann, J. (2012) · BMJ · doi:10.1136/bmj.e7492 · Cited by 1,629 · cited 2× · see citing works
“The Journal of Nutrition 513 2012; 142(7): 1304-13.”
BackgroundSelf-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,245 · see citing works
Aune, D., Chan, D. S. M., Lau, R., Vieira, R., Greenwood, D. C., Kampman, E., & Norat, T. (2011) · BMJ · doi:10.1136/bmj.d6617 · Cited by 1,146 · see citing works
Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies
Barclay, A. W., Petocz, P., McMillan-Price, J., Flood, V. M., Prvan, T., Mitchell, P., & Brand-Miller, J. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.627 · Cited by 1,061 · see citing works
Aune, D., Keum, N., Giovannucci, E., Fadnes, L. T., Boffetta, P., Greenwood, D. C., Tonstad, S., Vatten, L. J., Riboli, E., & Norat, T. (2016) · BMJ · doi:10.1136/bmj.i2716 · Cited by 1,013 · see citing works
Stephen, A. M., Champ, M. M.-J., Cloran, S. J., Fleith, M., van Lieshout, L., Mejborn, H., & Burley, V. J. (2017) · Nutrition Research Reviews · doi:10.1017/s095442241700004x · Cited by 798 · see citing works
Gardner, C. D., Trepanowski, J. F., Del Gobbo, L. C., Hauser, M. E., Rigdon, J., Ioannidis, J. P. A., Desai, M., & King, A. C. (2018) · JAMA · doi:10.1001/jama.2018.0245 · Cited by 709 · see citing works
Bioavailability of iron, zinc, and other trace minerals from vegetarian diets
Hunt, J. R. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.633s · Cited by 637 · see citing works
(2013) · The Journal of Nutrition · doi:10.3945/jn.111.155325 · Cited by 634 · see citing works
Mechanism of action of dietary fibre in the human colon
Stephen, A. M., & Cummings, J. H. (1980) · Nature · doi:10.1038/284283a0 · Cited by 503 · see citing works
Self-citationJärvi, A. E., Karlström, B. E., Granfeldt, Y. E., Björck, I. E., Asp, N. G., & Vessby, B. O. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.10 · Cited by 484 · see citing works
Wanders, A. J., van den Borne, J. J. G. C., de Graaf, C., Hulshof, T. G., Jonathan, M. C., Kristensen, M., Mars, M., Schols, H. A., & Feskens, E. J. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00895.x · Cited by 461 · see citing works
Bhupathiraju, S. N., Tobias, D. K., Malik, V. S., Pan, A., Hruby, A., Manson, J. E., Willett, W. C., & Hu, F. B. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.079533 · Cited by 402 · see citing works
CRC Handbook of Dietary Fiber in Human Nutrition
(2001) · CRC Press eBooks · doi:10.1201/9781420038514 · Cited by 383 · see citing works
The effect of fiber on satiety and food intake: a systematic review
Clark, M. J., & Slavin, J. L. (2013) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.791194 · Cited by 368 · see citing works
Ye, E. Q., Chacko, S. A., Chou, E. L., Kugizaki, M., & Liu, S. (2012) · Journal of Nutrition · doi:10.3945/jn.113.179473 · Cited by 257 · see citing works
Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates
Elia, M., & Cummings, J. H. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602938 · Cited by 234 · see citing works
Self-citationCRC Handbook of Dietary Fiber in Human Nutrition, Third Edition
Spiller, G. A. (1992) · Cited by 188 · see citing works
Mirrahimi, A., de Souza, R. J., Chiavaroli, L., Sievenpiper, J. L., Beyene, J., Hanley, A. J., Augustin, L. S. A., Kendall, C. W. C., & Jenkins, D. J. A. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000752 · Cited by 161 · see citing works
Cummings, J. H. (1973) · Gut · doi:10.1136/gut.14.1.69 · Cited by 160 · see citing works
Self-citationFeeding the microbiota: Transducer of nutrient signals for the host
Shanahan, F., van Sinderen, D., O’Toole, P. W., & Stanton, C. (2017) · Gut · doi:10.1136/gutjnl-2017-313872 · Cited by 157 · see citing works
Diabetes, Coronary Thrombosis, and the Saccharine Disease.
Bouchier, I. A. D. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-67-6-1361_2 · Cited by 149 · see citing works
Fan, J., Song, Y., Wang, Y., Hui, R., & Zhang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052182 · Cited by 148 · see citing works
Dong, J.-Y., Zhang, L., Zhang, Y.-H., & Qin, L.-Q. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100540x · Cited by 124 · see citing works
Refined Carbohydrate Foods and Disease
(1975) · Elsevier eBooks · doi:10.1016/b978-0-12-144750-2.x5001-3 · Cited by 105 · see citing works
High glycemic index and glycemic load are associated with moderately increased cancer risk
Turati, F., Galeone, C., Gandini, S., Augustin, L. S. A., Jenkins, D. J. A., Pelucchi, C., & Vecchia, C. L. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400594 · Cited by 97 · see citing works
Liu, L., Wang, S., & Liu, J. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400449 · Cited by 97 · see citing works
Denis Burkitt and the origins of the dietary fibre hypothesis
Cummings, J. H., & Engineer, A. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422417000117 · Cited by 70 · see citing works
Self-citationCai, X., Wang, C., Wang, S., Cao, G., Jin, C., Yu, J., Li, X., Yan, J., Wang, F., Yu, W., et al. (2015) · Asia Pacific Journal of Public Health · doi:10.1177/1010539514566742 · Cited by 47 · see citing works
Pure, White and Deadly: The Problem of Sugar.
(1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb110816.x · Cited by 34 · see citing works
Rossi, M., Turati, F., Λάγιου, Π., Trichopoulos, D., Vecchia, C. L., & Trichopoulou, A. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0702-3 · Cited by 17 · see citing works
Trowell, H. C., & Burkitt, D. P. (1975) · Elsevier eBooks · doi:10.1016/b978-0-12-144750-2.50027-9 · Cited by 7 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Aune, 2011, Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies, BMJ, 343, d6617, 10.1136/bmj.d6617 · DOI · Paper page
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175 · see citing works
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300 · see citing works
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485 · see citing works
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · see citing works
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784 · see citing works
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800 · see citing works
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598 · see citing works
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R. D., Pontefract, B., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,107 · see citing works
Lichtenstein, A. H., Appel, L. J., Vadiveloo, M., Hu, F. B., Kris-Etherton, P. M., Rebholz, C. M., Sacks, F. M., Thorndike, A. N., Van Horn, L., Wylie-Rosett, J., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001031 · Cited by 1,065 · see citing works
Microbial Regulation of Host Physiology by Short-chain Fatty Acids
van der Hee, B., & Wells, J. M. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.02.001 · Cited by 982 · see citing works
Dietary fibre in gastrointestinal health and disease
Gill, S. K., Rossi, M., Bajka, B., & Whelan, K. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00375-4 · Cited by 979 · see citing works
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893 · see citing works
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
O’Riordan, K. J., Collins, M., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G. A., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 742 · see citing works
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 694 · see citing works
Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K., & Elinav, E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.006 · Cited by 578 · see citing works
Gasaly, N., de Vos, P., & Hermoso, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658354 · Cited by 596 · see citing works
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596 · see citing works
Dietary Fiber, Atherosclerosis, and Cardiovascular Disease
Soliman, G. A. (2019) · Nutrients · doi:10.3390/nu11051155 · Cited by 576 · see citing works
Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses
Reynolds, A. N., Akerman, A. P., & Mann, J. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003053 · Cited by 567 · see citing works
Self-citationTrends in Dietary Carbohydrate, Protein, and Fat Intake and Diet Quality Among US Adults, 1999-2016
Shan, Z., Rehm, C. D., Rogers, G. T., Ruan, M., Wang, D. D., Hu, F. B., Mozaffarian, D., Zhang, F. F., & Bhupathiraju, S. N. (2019) · JAMA · doi:10.1001/jama.2019.13771 · Cited by 558 · see citing works
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab154 · Cited by 565 · see citing works
Deehan, E. C., Yang, C., Pérez-Muñoz, M. E., Nguyen, N. K., Cheng, C. C., Triador, L., Zhang, Z., Bakal, J. A., & Walter, J. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.006 · Cited by 549 · see citing works
Gut microbiota-derived short-chain fatty acids and their role in human health and disease
Mukhopadhya, I., & Louis, P. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01183-w · Cited by 586 · see citing works
The EAT–Lancet Commission on healthy, sustainable, and just food systems
Rockström, J., Thilsted, S. H., Willett, W. C., Gordon, L. J., Herrero, M., Hicks, C. C., Mason-D’Croz, D., Rao, N., Springmann, M., Wright, E. C., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01201-2 · Cited by 542 · see citing works
An Update on the Epidemiology of Type 2 Diabetes
Tinajero, M., & Malik, V. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.013 · Cited by 505 · see citing works
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
Uusitupa, M. I. J., Khan, T. A., Viguiliouk, E., Kahleová, H., Rivellese, A. A., Hermansen, K., Pfeiffer, A. F. H., Thanopoulou, A. C., Salas‐Salvadó, J., Schwab, U., et al. (2019) · Nutrients · doi:10.3390/nu11112611 · Cited by 488 · see citing works
Chambers, E. S., Byrne, C. S., Morrison, D. J., Murphy, K. G., Preston, T., Tedford, C., Garcia-Perez, I., Fountana, S., Serrano-Contreras, J. I., Holmes, E., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318424 · Cited by 443 · see citing works
Li, N., Lu, B., Luo, C., Cai, J., Lu, M., Zhang, Y., Chen, H., & Dai, M. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.034 · Cited by 447 · see citing works
Nordic Nutrition Recommendations 2023
Blomhoff, R., Andersen, R., Arnesen, E., Christensen, J. J., Eneroth, H., Erkkola, M., Gudanaviciene, I., Halldorsson, T. I., Høyer-Lund, A., Lemming, E. W., et al. (2023) · Nordic Council of Ministers eBooks · doi:10.6027/nord2023-003 · Cited by 455 · see citing works
Kaye, D. M., Shihata, W., Jama, H. A., Tsyganov, K., Ziemann, M., Kiriazis, H., Horlock, D., Vijay, A., Giam, B., Vinh, A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043081 · Cited by 415 · see citing works
Dietary Fibre from Whole Grains and Their Benefits on Metabolic Health
P., N. P. V., & Joye, I. J. (2020) · Nutrients · doi:10.3390/nu12103045 · Cited by 387 · see citing works
The Role of the Gut Microbiota in the Relationship Between Diet and Human Health
Perler, B. K., Friedman, E. S., & Wu, G. D. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031522-092054 · Cited by 385 · see citing works
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362 · see citing works
The effects of plant-based diets on the body and the brain: a systematic review
Medawar, E., Hühn, S., Villringer, A., & Witte, A. V. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0552-0 · Cited by 355 · see citing works
Beukema, M., Faas, M. M., & de Vos, P. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0449-2 · Cited by 337 · see citing works
Plant-based diets to manage the risks and complications of chronic kidney disease
Carrero, J. J., González-Ortíz, A., Avesani, C. M., Bakker, S. J. L., Bellizzi, V., Chauveau, P., Clase, C. M., Cupisti, A., Espinosa-Cuevas, Á., Molina, P., et al. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0297-2 · Cited by 334 · see citing works
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s005 · Cited by 445 · see citing works
Bioactive potential of fruit and vegetable wastes
Coman, V., Teleky, B., Mitrea, L., Martău, G. A., Szabo, K., Călinoiu, L. F., & Vodnar, D. C. (2019) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2019.07.001 · Cited by 328 · see citing works
The gut microbiota in obesity and weight management: microbes as friends or foe?
Hul, M. V., & Cani, P. D. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00794-0 · Cited by 335 · see citing works
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s005 · Cited by 299 · see citing works
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works
Grains – a major source of sustainable protein for health
Poutanen, K. S., Kårlund, A., Gómez-Gallego, C., Johansson, D. P., Scheers, N., Marklinder, I., Eriksen, A. K., Silventoinen, P., Nordlund, E., Sözer, N., et al. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab084 · Cited by 318 · see citing works
Charchar, F. J., Prestes, P. R., Mills, C. E., Ching, S. M., Neupane, D., Marques, F. Z., Sharman, J. E., Vogt, L., Burrell, L. M., Коростовцева, Л. С., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003563 · Cited by 352 · see citing works
ElSayed, N. A., Aleppo, G., Bannuru, R. R., Beverly, E. A., Bruemmer, D., Collins, B. S., Darville, A. K., Ekhlaspour, L., Hassanein, M. M., Hilliard, M. E., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s005 · Cited by 325 · see citing works
The gut microbiome and hypertension
O’Donnell, J. A., Zheng, T., Méric, G., & Marques, F. Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00654-0 · Cited by 294 · see citing works
Role of Diet in Colorectal Cancer Incidence
Veettil, S. K., Wong, T. Y., Loo, Y. S., Playdon, M. C., Lai, N. M., Giovannucci, E. L., & Chaiyakunapruk, N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37341 · Cited by 284 · see citing works
Evidence-based European recommendations for the dietary management of diabetes
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Aas, A.-M., Axelsen, M., Churuangsuk, C., Hermansen, K., Kendall, C. W. C., Kahleova, H., Khan, T., Lean, M. E. J., Mann, J. I., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05894-8 · Cited by 262 · see citing works
Self-citationRethinking healthy eating in light of the gut microbiome
Armet, A. M., Deehan, E. C., O’Sullivan, A. F., Mota, J. F., Field, C. J., Prado, C. M., Lucey, A. J., & Walter, J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.04.016 · Cited by 252 · see citing works
Livesey, G., Taylor, R., Livesey, H. F., Buyken, A. E., Jenkins, D. J. A., Augustin, L. S. A., Sievenpiper, J. L., Barclay, A. W., Liu, S., Wolever, T. M. S., et al. (2019) · Nutrients · doi:10.3390/nu11061280 · Cited by 247 · see citing works
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC · doi:10.1016/j.jacc.2025.11.016 · Cited by 304 · see citing works
Diet, nutrition, and cancer risk: what do we know and what is the way forward?
Key, T. J., Bradbury, K. E., Perez‐Cornago, A., Sinha, R. R., Tsilidis, K. K., & Tsugane, S. (2020) · BMJ · doi:10.1136/bmj.m511 · Cited by 243 · see citing works
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
Jenkins, D. J. A., Dehghan, M., Mente, A., Bangdiwala, S. I., Rangarajan, S., Srichaikul, K., Mohan, V., Avezum, Á., Díaz, R., Rosengren, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2007123 · Cited by 234 · see citing works
Birkeland, E., Gharagozlian, S., Birkeland, K. I., Valeur, J., Måge, I., Rud, I., & Aas, A. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02282-5 · Cited by 234 · see citing works
Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes
Bolla, A. M., Caretto, A., Laurenzi, A., Scavini, M., & Piemonti, L. (2019) · Nutrients · doi:10.3390/nu11050962 · Cited by 226 · see citing works
Changes in Plant-Based Diet Quality and Total and Cause-Specific Mortality
Baden, M. Y., Liu, G., Satija, A., Li, Y., Sun, Q., Fung, T. T., Rimm, E. B., Willett, W. C., Hu, F. B., & Bhupathiraju, S. N. (2019) · Circulation · doi:10.1161/circulationaha.119.041014 · Cited by 228 · see citing works
Leveraging diet to engineer the gut microbiome
Wolter, M., Grant, E. T., Boudaud, M., Steimle, A., Pereira, G. V., Martens, E. C., & Desai, M. S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00512-7 · Cited by 211 · see citing works
Poole, N., Donovan, J., & Erenstein, O. (2020) · Food Policy · doi:10.1016/j.foodpol.2020.101976 · Cited by 221 · see citing works
Modulation of the human gut microbiota by phenolics and phenolic fiber‐rich foods
Loo, Y. T., Howell, K. S., Chan, M., Zhang, P., & Ng, K. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12563 · Cited by 216 · see citing works
Chen, C., Chaudhary, A., & Mathys, A. (2019) · Nutrients · doi:10.3390/nu11040856 · Cited by 222 · see citing works
Plant-Based Diets for Cardiovascular Disease Prevention: All Plant Foods Are Not Created Equal
Hemler, E. C., & Hu, F. B. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0779-5 · Cited by 205 · see citing works
Boyland, E. J., McGale, L. S., Maden, M., Hounsome, J. C., Boland, A., Angus, K., & Jones, A. (2022) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.1037 · Cited by 215 · see citing works
Risk Factors for Colorectal Polyps and Cancer
Sninsky, J. A., Shore, B. M., Lupu, G. V., & Crockett, S. D. (2022) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2021.12.008 · Cited by 207 · see citing works
Contribution of macronutrients to obesity: implications for precision nutrition
San-Cristóbal, R., Navas‐Carretero, S., Martínez‐González, M. Á., Ordovás, J. M., & Martínez, J. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0346-8 · Cited by 201 · see citing works
Incident type 2 diabetes attributable to suboptimal diet in 184 countries
O’Hearn, M., Lara-Castor, L., Cudhea, F., Miller, V., Reedy, J., Shi, P., Zhang, J., Wong, J. B., Economos, C. D., Micha, R., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02278-8 · Cited by 202 · see citing works
Association of Low-Carbohydrate and Low-Fat Diets with Mortality Among US Adults
Shan, Z., Guo, Y., Hu, F. B., Liu, L., & Qi, Q. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.6980 · Cited by 192 · see citing works
Nguyen, N. K., Deehan, E. C., Zhang, Z., Jin, M., Baskota, N., Pérez-Muñoz, M. E., Cole, J. L., Tunçil, Y. E., Seethaler, B., Wang, T., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00887-w · Cited by 192 · see citing works
Seal, C. J., Courtin, C. M., Venema, K., & de Vries, J. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12728 · Cited by 190 · see citing works
Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability
Meyers, G. R., Samouda, H., & Bohn, T. (2022) · Nutrients · doi:10.3390/nu14245361 · Cited by 193 · see citing works
O’Keefe, S. J. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30257-2 · Cited by 190 · see citing works
Arabinoxylans as Functional Food Ingredients: A Review
Zannini, E., Bravo‐Núñez, Á., Sahin, A. W., & Arendt, E. K. (2022) · Foods · doi:10.3390/foods11071026 · Cited by 185 · see citing works
Mediterranean diet in the management and prevention of obesity
Dominguez, L. J., Veronese, N., Bella, G. D., Cusumano, C., Parisi, A., Tagliaferri, F., Ciriminna, S., & Barbagallo, M. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112121 · Cited by 192 · see citing works
How Important are Cereals and Cereal Products in the Average Polish Diet?
Laskowski, W., Górska-Warsewicz, H., Rejman, K., Czeczotko, M., & Zwolińska, J. (2019) · Nutrients · doi:10.3390/nu11030679 · Cited by 184 · see citing works
Reynolds, A. N., Akerman, A. P., Kumar, S., Pham, H. T. D., Coffey, S., & Mann, J. I. (2022) · BMC Medicine · doi:10.1186/s12916-022-02328-x · Cited by 192 · see citing works
Self-citationA Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
Diab, A., Dastmalchi, L. N., Gulati, M., & Michos, E. D. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s379874 · Cited by 202 · see citing works
Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men
Ma, W., Nguyen, L. H., Song, M., Wang, D. D., Franzosa, E. A., Cao, Y., Joshi, A. D., Drew, D. A., Mehta, R. S., Ivey, K. L., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00921-y · Cited by 178 · see citing works
Oliver, A., Chase, A. B., Weihe, C., Orchanian, S. B., Riedel, S. F., Hendrickson, C. L., Lay, M., Sewall, J. M., Martiny, J. B. H., & Whiteson, K. (2021) · mSystems · doi:10.1128/msystems.00115-21 · Cited by 171 · see citing works
Christensen, L., Vuholm, S., Roager, H. M., Nielsen, D. S., Krych, L., Kristensen, M., Astrup, A., & Hjorth, M. F. (2019) · The Journal of Nutrition · doi:10.1093/jn/nxz198 · Cited by 162 · see citing works
The Gut Microbiome in Hypertension
Avery, E. G., Bartolomaeus, H., Maifeld, A., Markó, L., Wiig, H., Wilck, N., Rosshart, S. P., Forslund, S. K., & Müller, D. N. (2021) · Circulation Research · doi:10.1161/circresaha.121.318065 · Cited by 174 · see citing works
Gut microbiome in modulating immune checkpoint inhibitors
Li, X., Zhang, S., Guo, G., Han, J., & Yu, J. Q. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104163 · Cited by 172 · see citing works
Vlachos, D., Malisova, S., Lindberg, F. A., & Karaniki, G. (2020) · Nutrients · doi:10.3390/nu12061561 · Cited by 168 · see citing works
Nanocellulose-stabilized Pickering emulsions: Fabrication, stabilization, and food applications
Ji, C., & Wang, Y. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102970 · Cited by 166 · see citing works
Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations
Livesey, G., Taylor, R., Livesey, H. F., Buyken, A. E., Jenkins, D. J. A., Augustin, L. S. A., Sievenpiper, J. L., Barclay, A. W., Liu, S., Wolever, T. M. S., et al. (2019) · Nutrients · doi:10.3390/nu11061436 · Cited by 163 · see citing works
McClements, D. J. (2020) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2020.106404 · Cited by 162 · see citing works
Schoeneck, M., & Iggman, D. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.032 · Cited by 161 · see citing works
Santos, H. O., Price, J. C., & Bueno, A. A. (2020) · Nutrients · doi:10.3390/nu12103159 · Cited by 157 · see citing works
Understanding whole‐wheat flour and its effect in breads: A review
Gómez, M., Gutkoski, L. C., & Bravo‐Núñez, Á. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12625 · Cited by 154 · see citing works
Mazidi, M., Katsiki, N., Mikhailidis, D. P., Sattar, N. A., & Banach, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz174 · Cited by 153 · see citing works
Dietary Factors and Risks of Cardiovascular Diseases: An Umbrella Review
Chareonrungrueangchai, K., Wongkawinwoot, K., Anothaisintawee, T., & Reutrakul, S. (2020) · Nutrients · doi:10.3390/nu12041088 · Cited by 158 · see citing works
Hydroxycinnamic acids and human health: recent advances
Coman, V., & Vodnar, D. C. (2019) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.10010 · Cited by 155 · see citing works
Gaesser, G. A. (2020) · Nutrients · doi:10.3390/nu12123756 · Cited by 157 · see citing works
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review
Chey, W. D., Hashash, J. G., Manning, L., & Chang, L. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.248 · Cited by 157 · see citing works
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Simpson, R. C., Shanahan, E. R., Scolyer, R. A., & Long, G. V. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00803-9 · Cited by 153 · see citing works
Mao, T., Huang, F., Zhu, X., Wei, D., & Chen, L. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104500 · Cited by 148 · see citing works
The gut microbiome: what the oncologist ought to know
Lee, K. A., Luong, M., Shaw, H. M., Nathan, P., Bataille, V. A., & Spector, T. D. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01467-x · Cited by 151 · see citing works
High-amylose wheat starch: Structural basis for water absorption and pasting properties
Li, C., Dhital, S., Gilbert, R. G., & Gidley, M. J. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116557 · Cited by 145 · see citing works
Effects of dietary fibre on metabolic health and obesity
Deehan, E. C., Mocanu, V., & Madsen, K. L. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00891-z · Cited by 155 · see citing works
Sievenpiper, J. L. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz082 · Cited by 144 · see citing works
Evaluating microbiome-directed fibre snacks in gnotobiotic mice and humans
Delannoy-Bruno, O., Desai, C., Raman, A. S., Chen, R. Y., Hibberd, M. C., Cheng, J., Han, N., Castillo, J. J., Couture, G., Lebrilla, C. B., et al. (2021) · Nature · doi:10.1038/s41586-021-03671-4 · Cited by 136 · see citing works
The role of the Mediterranean diet on weight loss and obesity-related diseases
Estruch, R., & Ros, E. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09579-0 · Cited by 147 · see citing works
Ultraprocessed Food: Addictive, Toxic, and Ready for Regulation
Lustig, R. H. (2020) · Nutrients · doi:10.3390/nu12113401 · Cited by 140 · see citing works
- Authors
- Reynolds, A., Mann, J., Cummings, J., Winter, N., Mete, E., & Te Morenga, L.
- Affiliations
- University of Otago (NZ)
- Riddet Institute (NZ)
- University of Dundee (GB)
- Corresponding author
- Mann, Jim
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 393
- Issue
- 10170
- Pages
- 434-445
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2910727162
- Semantic Scholar
- 4d32053514c1f32591141e1cb35a4f5e2fa8821f
- Cited by
- 1,630
- References
- 46
- Citations by year
- 2026: 196 · 2025: 239 · 2024: 227 · 2023: 249 · 2022: 243 · 2021: 206 · 2020: 163 · 2019: 106
- FWCI
- 24.38
- Type
- journal article
- Language
- en
- Update notices
- erratum (2019-02-02)
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc-nd)
- Funders
- World Health Organization
- University of Otago
- Health Research Council of New Zealand
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- carbohydrate quality, dietary fiber, whole grains, glycemic index, glycemic load, non-communicable diseases, cardiovascular disease, type 2 diabetes, colorectal cancer, breast cancer, all-cause mortality, stroke, coronary artery disease, body weight, blood pressure, total cholesterol, dose-response relationship, dietary recommendations, dietary diversity
- MeSH terms
- Noncommunicable Diseases, Dietary Carbohydrates, Dietary Fiber, Humans, Primary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review